XP-102

DB18780InvestigationalSmall molecule

XP-102: Overview.

Mechanism: Pharmacologically active on RAF proto-oncogene serine/threonine-protein kinase and Serine/threonine-protein kinase B-raf
Curator reviewed
Formula / weight: C₂₈H₃₃F₂N₇O₂S · 569.68 g/mol (avg)
Code names: BI-882370 · XP-102

Resolves to

Compound

Structure

InChIKeyAEJACXAFHXBVHF-UHFFFAOYSA-NSMILESCCCS(=O)(=O)NC1=CC=C(F)C(N2C=C(C3=NC(=CC=C23)N(C)C2CCN(CC)CC2)C2=CN=CN=C2)=C1F

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with XP-102, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.